Floatz logo

BAY-Q-3939

Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax

BayerDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax cohort.

Asset / SponsorPhaseRating
Ciprofloxacin
Bayer
D

Same molecule, other indications

BAY-Q-3939 is also rated in:

bronchiectasisDormant
B
Indicative ·
57 / 100
View asset →
cystic fibrosisDormant
CCC
Indicative ·
54 / 100
View asset →
Pseudomonas infectionDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →